X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (44) 44
humans (24) 24
male (23) 23
middle aged (13) 13
oncology (13) 13
female (12) 12
adult (11) 11
aged (11) 11
animals (11) 11
cardiac & cardiovascular systems (11) 11
proteins (10) 10
expression (9) 9
inflammation (9) 9
macrophages (9) 9
medicine, research & experimental (9) 9
studies (9) 9
apoptosis (8) 8
care and treatment (8) 8
kinases (8) 8
rats (8) 8
atherosclerosis (7) 7
cancer (7) 7
cardiovascular disease (7) 7
cell line (7) 7
development and progression (7) 7
health aspects (7) 7
heart (7) 7
patients (7) 7
prognosis (7) 7
abridged index medicus (6) 6
analysis (6) 6
autophagy (6) 6
gene expression (6) 6
research (6) 6
rodents (6) 6
berberine (5) 5
biomarkers (5) 5
cancer therapies (5) 5
cardiology (5) 5
cardiovascular (5) 5
chemotherapy (5) 5
diagnosis (5) 5
electrocardiography (5) 5
gastric cancer (5) 5
heart attacks (5) 5
heart failure (5) 5
mice (5) 5
mortality (5) 5
oxidative stress (5) 5
pathway (5) 5
pharmacology & pharmacy (5) 5
prevention (5) 5
activation (4) 4
aged, 80 and over (4) 4
apoptosis - drug effects (4) 4
articles (4) 4
atrial fibrillation (4) 4
carcinoma (4) 4
cardiac arrhythmia (4) 4
cell activation (4) 4
cell growth (4) 4
cholesterol (4) 4
disease (4) 4
enzyme-linked immunosorbent assay (4) 4
fibrosis (4) 4
flow cytometry (4) 4
genetic aspects (4) 4
heart diseases (4) 4
hypoxia (4) 4
life sciences (4) 4
management (4) 4
medical imaging (4) 4
medicine, general & internal (4) 4
metastasis (4) 4
microrna (4) 4
monocytes (4) 4
myocardial infarction (4) 4
risk (4) 4
statins (4) 4
stomach neoplasms - pathology (4) 4
treatment outcome (4) 4
ampk (3) 3
autophagy - drug effects (3) 3
berberine - pharmacology (3) 3
biopsy (3) 3
breast cancer (3) 3
cardiomyocytes (3) 3
catheter ablation - methods (3) 3
cell adhesion & migration (3) 3
cell biology (3) 3
cell cycle (3) 3
cell lung-cancer (3) 3
cells (3) 3
clinical trials (3) 3
cytokines (3) 3
diagnosis, differential (3) 3
differentiation (3) 3
emmprin expression (3) 3
heart attack (3) 3
heart failure - physiopathology (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2014, Volume 63, Issue 1, pp. 62 - 70
Objectives This study sought to evaluate the safety and efficacy of rosuvastatin in preventing contrast-induced acute kidney injury (CI-AKI) in patients with... 
Cardiovascular | Internal Medicine | kidney | diabetes mellitus | contrast medium | statins | angiography | C-REACTIVE PROTEIN | CARDIAC & CARDIOVASCULAR SYSTEMS | CARDIOTHORACIC SURGERY | INDUCED NEPHROPATHY | RISK | ATORVASTATIN | SERUM CREATININE | TRIAL | PERCUTANEOUS CORONARY INTERVENTION | PRETREATMENT | STATIN THERAPY | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Renal Insufficiency, Chronic - diagnostic imaging | Male | Fluorobenzenes - administration & dosage | Renal Insufficiency, Chronic - complications | Diabetes Mellitus, Type 2 - diagnostic imaging | Dose-Response Relationship, Drug | Contrast Media - adverse effects | Time Factors | Angiography - methods | Female | Acute Kidney Injury - chemically induced | Diabetes Mellitus, Type 2 - complications | Pyrimidines - administration & dosage | Rosuvastatin Calcium | Treatment Outcome | Acute Kidney Injury - prevention & control | Angiography - adverse effects | Sulfonamides - therapeutic use | Pyrimidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Fluorobenzenes - therapeutic use | Sulfonamides - administration & dosage | Prevention | Diabetics | Medical colleges | Care and treatment | Chronic kidney failure | Rosuvastatin | Diabetes | Diabetes therapy | Antilipemic agents | Heart failure | Oxidative stress | Heart attacks | Medical imaging | Statistical analysis | Hydration | Clinical trials | Kidney diseases | Drug therapy | Acute coronary syndromes | Cholesterol
Journal Article
International Journal of Oncology, ISSN 1019-6439, 02/2018, Volume 52, Issue 2, pp. 589 - 598
CKLF-like MARVEL transmembrane domain containing 3 (CMTM3) is considered to be a tumor suppressor gene in multiple types of malignancies. Previous studies have... 
Proliferation | Gastric cancer | Invasion | CKLF-like MARVEL transmembrane domain containing 3 | MicroRNA-135b-5p | MIGRATION | gastric cancer | proliferation | DNA METHYLATION | STATISTICS | DOWN-REGULATION | microRNA-135b-5p | CELL LUNG-CANCER | invasion | ONCOLOGY | GENES | EXPRESSION | TUMORIGENESIS | CARCINOMA
Journal Article
Journal of Electrocardiology, ISSN 0022-0736, 2013, Volume 46, Issue 6, pp. 676 - 678
Journal Article
American Journal of Surgery, The, ISSN 0002-9610, 2011, Volume 202, Issue 5, pp. 605 - 611
Journal Article
Journal of Cancer, ISSN 1837-9664, 2018, Volume 9, Issue 7, pp. 1188 - 1199
Purpose: We explored the influence of age on clinicopathologic features and survival of patients with M0 gastric cancer (GC). Methods: 16856 GC patients from... 
Survival analysis | SEER | Retrospective study | Gastric cancer | Age | SURVIVAL | DIAGNOSIS | RISK-FACTORS | TUMOR MICROSATELLITE INSTABILITY | ADENOCARCINOMA | YOUNG-PATIENTS | NO ALARM SYMPTOMS | CLINICOPATHOLOGICAL CHARACTERISTICS | survival analysis | ONCOLOGY | PROSTATE-CANCER | CARCINOMA | age | retrospective study
Journal Article
Oncology Letters, ISSN 1792-1074, 07/2018, Volume 16, Issue 1, pp. 573 - 579
Although tamoxifen is the most frequently used drug for the treatment of estrogen receptor positive (ER+)-breast cancer (BRCA), its efficacy varies between... 
Tamoxifen | Breast cancer | Prognosis | METASTASIS | ONCOLOGY | STATISTICS | PATHWAY | RESISTANCE | breast cancer | ENDOCRINE THERAPY | prognosis | tamoxifen
Journal Article
by Ray, Kausik K and Ray, Michael and Colhoun, Helen M and Szarek, Michael and Baccara-Dinet, Marie and Bhatt, Deepak L and Bittner, Vera A and Budaj, Andrzej J and Budaj, Andrzej and Diaz, Rafael and Diaz, Ariel and Goodman, Shaun G and Hanotin, Corinne and Harrington, Robert A and Jukema, J Wouter and Jukema, J. Wouter and Jukema, Johan and Loizeau, Virginie and Lopes, Renato D and Lopes, Renato and Moryusef, Angèle and Murin, Jan and Pordy, Robert and Ristic, Arsen D and Roe, Matthew T and Tuñón, José and White, Harvey D and White, Matthew and White, Lindsey and Zeiher, Andreas M and Schwartz, Steven and Schwartz, Michael and Schwartz, Gregory G and Steg, Philippe Gabriel and Steg, Ph. Gabriel and Tricoci, Pierluigi and Mahaffey, Kenneth W and Edelberg, Jay M and Lecorps, Guillaume and Sasiela, William J and Tamby, Jean-François and Aylward, Philip E and Drexel, Heinz and Sinnaeve, Peter and Dilic, Mirza and Gotcheva, Nina N and Prieto, Juan-Carlos and Prieto, Juan C and Yong, Huo and López-Jaramillo, Patricio and Pećin, Ivan and Reiner, Zeljko and Ostadal, Petr and Viigimaa, Margus and Nieminen, Markku S and Chumburidze, Vakhtang and Marx, Roger and Marx, Nikolaus and Danchin, Nicolas and Liberopoulos, Evangelos and Montenegro Valdovinos, Pablo Carlos and Tse, Hung-Fat and Kiss, Robert Gabor and Xavier, Denis and Zahger, Doron and Valgimigli, Marco and Kimura, Kazuo and Kimura, Takeshi and Kim, Sang-Hyun and Kim, Youngkwon and Kim, Chongjin and Kim, Hyo Soo and Kim, Hack-Lyoung and Kim, Moo Hyun and Kim, Hyo-Soo and Kim, Hae Young and Erglis, Andrejs and Laucevicius, Aleksandras and Kedev, Sasko and Yusoff, Khalid and Ramos López, Gabriel Arturo and Alings, Marco and Halvorsen, Sigrun and Correa Flores, Roger M and Morais, Joao and Dorobantu, Maria and Karpov, Yuri and Karpov, Yuriy and Chua, Terrance and Fras, Zlatko and Dalby, Anthony J and de Silva, H. Asita and Hagström, Emil and Landmesser, Ulf and Chiang, Chern-En and Sritara, Piyamitr and Guneri, Sema and Parkhomenko, Alexander and Moriarty, Patrick M and Moriarty, Katie and ... and ODYSSEY OUTCOMES Comm Investigato and ODYSSEY OUTCOMES Committees and Investigators
The Lancet Diabetes & Endocrinology, ISSN 2213-8587, 08/2019, Volume 7, Issue 8, pp. 618 - 628
After acute coronary syndrome, diabetes conveys an excess risk of ischaemic cardiovascular events. A reduction in mean LDL cholesterol to 1·4–1·8 mmol/L with... 
MYOCARDIAL-INFARCTION | LIRAGLUTIDE | STATIN THERAPY | BLOOD-GLUCOSE | GUIDELINES | ENDOCRINOLOGY & METABOLISM | RISK | PCSK9 | GENETIC-VARIANTS | ASSOCIATION | EVOLOCUMAB
Journal Article